Johnson & Johnson Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Joaquin Duato
Chief executive officer
US$13.1m
Total compensation
| CEO salary percentage | 11.4% |
| CEO tenure | 2yrs |
| CEO ownership | 0.01% |
| Management average tenure | 4.8yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Oct 01 2023 | n/a | n/a | US$14b |
| Jul 02 2023 | n/a | n/a | US$14b |
| Apr 02 2023 | n/a | n/a | US$13b |
| Jan 01 2023 | US$13m | US$1m | US$18b |
| Oct 02 2022 | n/a | n/a | US$18b |
| Jul 03 2022 | n/a | n/a | US$17b |
| Apr 03 2022 | n/a | n/a | US$20b |
| Jan 02 2022 | US$14m | US$1m | US$21b |
| Oct 03 2021 | n/a | n/a | US$18b |
| Jul 04 2021 | n/a | n/a | US$18b |
| Apr 04 2021 | n/a | n/a | US$15b |
| Jan 03 2021 | n/a | n/a | US$15b |
| Sep 27 2020 | n/a | n/a | US$17b |
| Jun 28 2020 | n/a | n/a | US$15b |
| Mar 29 2020 | n/a | n/a | US$17b |
| Dec 29 2019 | US$13m | US$970k | US$15b |
| Sep 29 2019 | n/a | n/a | US$14b |
| Jun 30 2019 | n/a | n/a | US$16b |
| Mar 31 2019 | n/a | n/a | US$15b |
| Dec 30 2018 | US$9m | US$934k | US$15b |
| Sep 30 2018 | n/a | n/a | US$2b |
| Jul 01 2018 | n/a | n/a | US$1b |
| Apr 01 2018 | n/a | n/a | US$1b |
| Dec 31 2017 | US$19m | US$897k | US$1b |
Compensation vs Market: Joaquin's total compensation ($USD13.10M) is above average for companies of similar size in the AR market ($USD5.76M).
Compensation vs Earnings: Joaquin's compensation has been consistent with company performance over the past year.
CEO
Joaquin Duato (60 yo)
2yrs
Tenure
US$13,099,487
Compensation
Mr. Joaquin Duato serves as Chief Executive Officer & Director of Johnson & Johnson since January 3, 2022 and serves as its Chairman since January 02, 2023. He served as Worldwide Chairman of Pharmaceutica...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 2yrs | US$13.10m | 0.013% $ 40.9b | |
| Executive VP & CFO | 5.5yrs | US$8.82m | 0.0022% $ 7.0b | |
| Executive VP & Worldwide Chairman of Innovative Medicine | 12yrs | US$8.78m | 0.0059% $ 18.8b | |
| Controller & Chief Accounting Officer | 4.1yrs | no data | 0.00073% $ 2.3b | |
| Executive VP & Chief Information Officer | 4.2yrs | no data | 0.00038% $ 1.2b | |
| Vice President of Investor Relations | 2.2yrs | no data | no data | |
| Chief Compliance Officer | no data | no data | no data | |
| Executive VP & General Counsel | 1.3yrs | no data | 0.00023% $ 738.9m | |
| Executive VP & Chief Human Resources Officer | 7.8yrs | US$3.62m | 0.0043% $ 13.7b | |
| Group Chairman of MD&D Business - EMEA | no data | no data | no data | |
| Executive VP | 17yrs | no data | 0.0036% $ 11.6b | |
| Executive VP and Chief Technical Operations & Risk Officer | 5.5yrs | no data | 0.0027% $ 8.8b |
4.8yrs
Average Tenure
57yo
Average Age
Experienced Management: DJNJ2's management team is considered experienced (4.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 2yrs | US$13.10m | 0.013% $ 40.9b | |
| Independent Director | 9.6yrs | US$350.00k | no data | |
| Lead Independent Director | 15yrs | US$410.00k | 0.00033% $ 1.1b | |
| Independent Director | 4.1yrs | US$340.00k | 0.00021% $ 674.7m | |
| Independent Director | 4.8yrs | US$353.59k | 0.00012% $ 385.5m | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | 10.3yrs | US$320.00k | no data | |
| Independent Director | 8.6yrs | US$360.00k | no data | |
| Independent Director | 1.9yrs | US$300.16k | 0.000040% $ 128.5m | |
| Independent Director | 5.8yrs | US$340.00k | no data | |
| Independent Director | 4.1yrs | US$340.00k | no data | |
| Independent Director | 3.1yrs | US$340.00k | no data |
4.4yrs
Average Tenure
62.5yo
Average Age
Experienced Board: DJNJ2's board of directors are considered experienced (4.4 years average tenure).